Skip to content
OpenCapital
Get started

SELLAS Life Sciences Group, Inc. SLS R&D

R&D at other companies

Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$58.85M-4.5%
Immunome logo
ImmunomeIMNM
$46.38M+25.8%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$122M0.0%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$75.37M+19.6%
Incyte logo
IncyteINCY
$515.9M+18.0%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$62.49M-17.7%

Other financials

Income statement

See full
Revenue-—
Gross profit-—
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$1.78B+674%
Enterprise value$1.68B+826%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%—

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0×0.0×
Current ratio17.2×+12.6×

Where this comes from

Reported directly by SELLAS Life Sciences Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s R&D?
SELLAS Life Sciences Group, Inc. (SLS) reported R&D of $5.13M in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s R&D changed year-over-year?
SELLAS Life Sciences Group, Inc.'s R&D increased by 60.0% year-over-year, from $3.21M to $5.13M.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s R&D?
Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s R&D has grown at a 0.6% compound annual growth rate (CAGR), from $15.67M to $16.02M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.